Trial Details
TERMINATEDBasic Information
| Clinical ID | c4560 |
|---|---|
| Identifier | NCT00325078 |
| Trial Title | Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Chronic Granulomatous Disease|Crohn'S-like IBD|Inflammatory Bowel Disease (IBD) |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| City | Bethesda |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2006-05 |
|---|---|
| Primary Completion Date | 2012-06 |
| Completion Date | 2012-06 |